Table of Contents Understanding Wegovy and Naproxen: What You Need to Know Wegovy (semaglutide) is a glucagon-like peptide-1 (GLP-1) receptor agonist licensed in the UK for chronic weight management in adults with obesity or overweight with weight-related comorbidities
Introduction Dipeptidyl peptidase-4 (DPP4) is a multifunctional protein that exerts biological activity through pleiotropic actions including: protease activity (1), association with adenosine deaminase (ADA) (2), interaction with the extracellular matrix (3), cell surface coreceptor activity mediating viral entry (4), and regulation of intracellular signal transduction coupled to control of cell migration and proliferation (5)
They should also call if nausea worsens after a dose increase, continues beyond the expected adjustment period, or is paired with vomiting, dizziness, abdominal pain, or dehydration
It can also increase the risk of pancreatitis
Oil-soluble vitamin C (like THD ascorbate) at neutral pH is generally compatible
Heliyon 2020;6:e05672